Target intelligence / Profile preview

RNA, U4 small nuclear 42, pseudogene (RNU4-42P)

Target
RNU4-42P
Molecular classification
Non-coding RNA, Pseudogene, Other
01

Overview

**RNU4-42P** (RNA, U4 small nuclear 42, pseudogene) is a non-coding RNA gene classified as a pseudogene, which means it resembles a functional gene but has lost its ability to code for a functional product due to mutations or deletions. Pseudogenes are typically not expressed or functional and do not produce biological effects in the cell. There is no evidence that RNU4-42P produces a protein or actively participates in known cellular processes, nor is it known to be involved in disease, serve as a drug target, or function as a biomarker. This distinguishes RNU4-42P from **RNU4-2** (RNA, U4 small nuclear 2), an active non-coding RNA gene of the major spliceosome that has recently been implicated in neurodevelopmental disorders[1][2][3][4]. No studies or drug databases identify RNU4-42P as a functional therapeutic target or as being involved in disease mechanisms.\n\n**Note:**\n- This target is likely an incorrect entry for therapeutic or research purposes. The functional molecule related to pre-mRNA splicing and neurodevelopmental disease is **RNU4-2**, not RNU4-42P.\n- There is no evidence that RNU4-42P has a role as a therapeutic, diagnostic, or pharmacological target in current biomedical literature, nor is it included in disease or drug-target databases[1][2][3][4].\n\nIf you are seeking information on the active, disease-associated U4 small nuclear RNA gene, refer to **RNU4-2**, which encodes the functional U4 snRNA and is fundamental to spliceosome biology and neurodevelopment[1][2][3][4].

Other names
RNU4-42P
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U4 small nuclear 42, pseudogene (RNU4-42P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 42, pseudogene (RNU4-42P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call